Want to stay updated on the latest news?
Create a Reader Account today to follow the industries and companies that interest you, and customize your news dashboard. SIGN INTO READER ACCOUNT CREATE READER ACCOUNT
Invivyd, Inc. (IVVD) Investor Alert: Robbins LLP Reminds Investors of Pending Lead Plaintiff Deadline in Invivyd, Inc. Class Action
March 24, 2023 13:44 ET
|
Robbins LLP
SAN DIEGO, March 24, 2023 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all purchasers of Invivyd, Inc. (NASDAQ: IVVD) f/k/a...
Truveta’s COVID-19 breakthrough infections research published in Vaccine
February 23, 2023 09:00 ET
|
Truveta
BELLEVUE, Wash., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Today Truveta announced new COVID-19 research published in Vaccine using de-identified patient data from Truveta Studio™. The new research...
Truveta’s COVID-19 breakthrough infections research published in Vaccine
February 23, 2023 09:00 ET
|
Truveta
BELLEVUE, Wash., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Today Truveta announced new COVID-19 research published in Vaccine using de-identified patient data from Truveta Studio™. The new research...
Invivyd, Inc. (IVVD) Class Action Alert: Robbins LLP Urges Shareholders to Contact the Firm Regarding Representation in the Class Action Against Invivyd, Inc.
February 16, 2023 15:03 ET
|
Robbins LLP
SAN DIEGO, Feb. 16, 2023 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all purchasers of Invivyd, Inc. (NASDAQ: IVVD) f/k/a...
Invivyd, Inc. (IVVD) f/k/a Adagio Therapeutics, Inc. Shareholder Notice: Robbins LLP Informs Investors of Class Action Against Invivyd, Inc. f/k/a Adagio Therapeutics, Inc.
February 07, 2023 13:05 ET
|
Robbins LLP
SAN DIEGO, Feb. 07, 2023 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all purchasers of Invivyd, Inc. (NASDAQ: IVVD) f/k/a...
Truveta’s COVID-19 health equity research published in Frontiers in Public Health
January 19, 2023 09:00 ET
|
Truveta
BELLEVUE, Wash., Jan. 19, 2023 (GLOBE NEWSWIRE) -- Today Truveta announced new COVID-19 health equity research published in Frontiers in Public Health using de-identified patient data from Truveta...
Veru Inc. (VERU) Equity Alert: Contact Robbins LLP for Information About the Class Action Against Veru Inc.
December 14, 2022 17:24 ET
|
Robbins LLP
SAN DIEGO, Dec. 14, 2022 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired Veru...
Truveta Studio delivers the health data and analytics the world deserves now
November 02, 2022 09:00 ET
|
Truveta
BELLEVUE, Wash., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Today, Truveta announced the availability of Truveta Studio, bringing together unprecedented health data and analytics for researchers to study...
Resverlogix Confirms Focus on Treatment of Post COVID-19 Conditions
September 28, 2022 07:12 ET
|
Resverlogix Corp
CALGARY, Alberta, Sept. 28, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the “Company”) (TSX:RVX) today announced that apabetalone’s future clinical development related to COVID-19...
The ¡Ándale! ¿Qué Esperas? Campaign Partners with Grupo Chespirito to Bring El Chavo Animado Vaccination Message to Parents & Children
April 05, 2022 10:00 ET
|
AltaMed
Los Angeles, April 05, 2022 (GLOBE NEWSWIRE) -- The ¡Ándale! ¿Qué Esperas? campaign by AltaMed Health Services partnered with Grupo Chespirito to produce a PSA featuring the iconic characters of...